CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 211 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02138461
NCT02138461N/ACompleted
CompareCT.gov

Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.

MDbackline, LLC·observational·Posted May 14, 2014·Updated Sep 25, 2014

In Brief

An observational study for Glaucoma. Completed, enrolled 211 participants across 1 site.

Detailed Summary

This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsAllergan

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 14, 2014
Enrollment StartOct 1, 2013
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.1 years ago